Chemoinformaics analysis of 3,4-Dihydroxyacetophenone
| Molecular Weight | 152.149 | nRot | 1 |
| Heavy Atom Molecular Weight | 144.085 | nRig | 7 |
| Exact Molecular Weight | 152.047 | nRing | 1 |
| Solubility: LogS | -1.013 | nHRing | 0 |
| Solubility: LogP | 0.87 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 21.1003 |
| nHD | 2 | BPOL | 8.89366 |
| QED | 0.471 |
| Synth | 1.754 |
| Natural Product Likeliness | 0.578 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.007 |
| HIA | 0.006 |
| CACO-2 | -4.602 |
| MDCK | 0.0000146 |
| BBB | 0.089 |
| PPB | 0.612869 |
| VDSS | 0.688 |
| FU | 0.300789 |
| CYP1A2-inh | 0.845 |
| CYP1A2-sub | 0.518 |
| CYP2c19-inh | 0.125 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.184 |
| CYP2c9-sub | 0.766 |
| CYP2d6-inh | 0.208 |
| CYP2d6-sub | 0.526 |
| CYP3a4-inh | 0.301 |
| CYP3a4-sub | 0.211 |
| CL | 13.195 |
| T12 | 0.905 |
| hERG | 0.017 |
| Ames | 0.385 |
| ROA | 0.146 |
| SkinSen | 0.731 |
| Carcinogencity | 0.359 |
| EI | 0.987 |
| Respiratory | 0.765 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.817335 |